EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Anti-Cadherin-19 Monoclonal Antibody (Ca19Mab-8) for Flow Cytometry, Western Blotting, and Immunohistochemistry

Guanjie Li iD, Hiroyuki Suzuki iD, Mika K Kaneko iD, Yukinari Kato iD

Current Issues in Molecular Biology · 12.03.2026 · 48 (3) · 307

DOI: 10.3390/cimb48030307 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 12.03.2026. Verfasst von Guanjie Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Miyagi, Japan. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The type II cadherin Cadherin-19 (CDH19) plays a crucial role in neural crest development. CDH19 regulates cell–cell junctions and migration by forming catenin–cytoskeleton complexes. Although anti-CDH19 monoclonal antibodies (mAbs) are used for specific applications such as Western blotting and immunohistochemistry (IHC), suitable anti-CDH19 mAbs for flow cytometry are limited. Therefore, developing mAbs that specifically recognize cell-surface-expressed CDH19 is essential for advancing both basic research and therapeutic strategies. Here, novel anti-human CDH19 mAbs (Ca19Mabs) were created using flow cytometry-based high-throughput screening. One clone, Ca19Mab-8 (IgG1, κ), specifically recognized CDH19-overexpressed Chinese hamster ovary-K1 cells but did not bind to other 21 CDHs (including both type I and type II CDHs) in flow cytometry. Additionally, Ca19Mab-8 recognized endogenous CDH19 in the human glioblastoma cell line LN229. The dissociation constant (KD) of Ca19Mab-8 for LN229/CDH19 was 9.0 × 10−9 M. Ca19Mab-8 also detected endogenous CDH19 in Western blotting. Furthermore, Ca19Mab-8 can detect CDH19 in IHC using human melanoma tissue. These findings suggest that Ca19Mab-8 is a novel mAb that detects cell-surface-expressed CDH19 with high specificity and is suitable for various applications in basic research. Therefore, Ca19Mab-8 has potential for clinical diagnosis and tumor therapy.

Schlagwörter

Stichwörter der Autor:innen

CDH19Cadherin-19cell-based immunization and screeningflow cytometryimmunohistochemistrymonoclonal antibody

Autor:innen und Institutionen

  • Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Miyagi, Japan.

ORCID-Profile: Guanjie Li, Hiroyuki Suzuki, Mika K Kaneko, Yukinari Kato

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science

Zitieren

APA

Li, G., Suzuki, H., Kaneko, M. K., & Kato, Y. (2026). A Novel Anti-Cadherin-19 Monoclonal Antibody (Ca19Mab-8) for Flow Cytometry, Western Blotting, and Immunohistochemistry. Current Issues in Molecular Biology, 48(3), 307. https://doi.org/10.3390/cimb48030307

Vancouver

Li G, Suzuki H, Kaneko MK, Kato Y. A Novel Anti-Cadherin-19 Monoclonal Antibody (Ca19Mab-8) for Flow Cytometry, Western Blotting, and Immunohistochemistry. Current Issues in Molecular Biology. 2026;48(3):307. doi:10.3390/cimb48030307

BibTeX
@article{Li2026,
  author = {Li, Guanjie and Suzuki, Hiroyuki and Kaneko, Mika K and Kato, Yukinari},
  title = {A Novel Anti-Cadherin-19 Monoclonal Antibody (Ca19Mab-8) for Flow Cytometry, Western Blotting, and Immunohistochemistry},
  journal = {Current Issues in Molecular Biology},
  year = {2026},
  volume = {48},
  number = {3},
  pages = {307},
  doi = {10.3390/cimb48030307}
}
Kostenlos starten →